<DOC>
	<DOCNO>NCT02939131</DOCNO>
	<brief_summary>IMPAACT 2002 prospective , multi-site , two-arm , cluster-randomized study evaluate whether health wellness Cognitive Behavioral Therapy Medication Management ( COMB-R ) intervention depression demonstrate improved depression medical outcome HIV-infected youth US compare enhance standard care ( ESC ) .</brief_summary>
	<brief_title>IMPAACT 2002 : Combined Cognitive Behavioral Therapy Medication Management Algorithm Treatment Depression Among US Youth With HIV</brief_title>
	<detailed_description>IMPAACT 2002 prospective , multi-site , two-arm , cluster-randomized study evaluate whether health wellness Cognitive Behavioral Therapy Medication Management ( COMB-R ) intervention depression demonstrate improved depression outcome ( e.g. , decrease depressive symptom great remission response rate ) medical outcome ( e.g. , increased CD4 T-cell count , decrease HIV RNA level ) among HIV-infected youth US compare enhance standard care ( ESC ) . Youth enrol study attend Screening/Entry Visit study visit Weeks 1 , 6 , 12 , 24 . They two additional follow-up visit Weeks 36 48 study team evaluate observe effect intervention maintain . The intervention treatment depression include manualized Health Wellness Cognitive Behavioral Therapy algorithm-driven Medication Management design address unique challenge face population .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<criteria>Receiving mental health HIVrelated care participate US IMPAACT site Confirmed HIV1 Infection Aware HIV infection Per clinician assessment , primary diagnosis nonpsychotic depression , include Major Depressive Disorder , Depression NOS , Dysthymia , define DSMIV DSMV criterion Current depressive symptom warrant intervention determine score â‰¥ 11 Quick Inventory Depressive Symptomatology Clinician ( QIDSC ) Able communicate spoken write English Able willing provide write informed assent/consent able obtain write parental guardian permission ( require , specify site SOP , State law , and/or IRB policy ) screen enroll IMPAACT 2002 Known selfreported history psychotic disorder and/or bipolar I II disorder Severe disorder ( 6 symptom ) base DSMV criterion ) relate alcohol , cannabis substance ; moderate symptom ( 4 5 symptom ) also currently experience withdrawal dependence symptom ; within past month prior enrollment Per clinician assessment screening , depression and/or suicidal ideation require intensive treatment study provide immediate risk danger others Per participant report screening , intend relocate away study site study participation Currently therapy nonstudy provider , unless willing switch studytrained provider Has condition , opinion Investigator Record ( IoR ) /designee , would preclude informed assent/consent , make study participation unsafe , complicate interpretation study outcome data , otherwise interfere achieve study objective</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>24 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Cognitive Behavioral Therapy</keyword>
	<keyword>Medication Management</keyword>
</DOC>